The impact of antihyperlipidemic drugs on the viral load of patients with chronic hepatitis C infection: a meta-analysis
Hepatitis B and survival after renal transplant: meta-analysis of observational studies
Hepatitis C virus 5′ untranslated region variability correlates with treatment outcome
Barriers and facilitators for assessment and treatment of hepatitis C virus infection in the opioid substitution treatment setting: insights from the ETHOS study
The number needed to treat to prevent mortality and cirrhosis-related complications among patients with cirrhosis and HCV genotype 1 infection
Genetic variation in toll-like receptors and retinoic acid-inducible gene I and outcome of hepatitis C virus infection: a candidate gene association study
Predictors of early treatment discontinuation in a cohort of patients treated with boceprevir-based therapy for hepatitis C infection
Relapse rates in chronic hepatitis B naïve patients after discontinuation of antiviral therapy with entecavir
Metformin inhibits hepatitis B virus protein production and replication in human hepatoma cells
Antiviral effect of entecavir in nucleos(t)ide analogue-naïve and nucleos(t)ide analogue-experienced chronic hepatitis B patients without virological response at week 24 or 48 of therapy
Exploration of genetically determined resistance against hepatitis C infection in high-risk injecting drug users
Hepatitis E infection in HIV-infected liver and kidney transplant candidates